TY - JOUR T1 - Pathogen spectra in hospitalised and non-hospitalised children with community acquired pneumonia JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00286-2022 SP - 00286-2022 AU - Martin Wetzke AU - Katharina Schütz AU - Matthias Volkmar Kopp AU - Jürgen Seidenberg AU - Christian Vogelberg AU - Tobias Ankermann AU - Christine Happle AU - Gesche Voigt AU - Holger Köster AU - Thomas Illig AU - Christiane Lex AU - Antje Schuster AU - Ralph Maier AU - Marcus Panning AU - Grit Barten AU - Gernot Rohde AU - Tobias Welte AU - Gesine Hansen Y1 - 2022/01/01 UR - http://openres.ersjournals.com/content/early/2022/09/22/23120541.00286-2022.abstract N2 - Paediatric community-acquired pneumonia (pedCAP) is one of the leading causes of childhood morbidity and mortality worldwide. Even in high income countries, it causes up to 20% of paediatric hospital admissions [1]. In Germany, annual hospitalisation rates of children below the age of 5 years with pedCAP are estimated to be around 90/10,000 [2]. However, a critical gap in the knowledge on etiology and management of pedCAP exists. Most pedCAP-studies thus far focused on hospitalised pedCAP, and longitudinal data on non-severe courses is scarce [3–5]. Detailed etiologic data in young age groups is particularly rare [4, 6, 7].FootnotesThis manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.Conflict of interests: Martin Wetzke received funding from the Young Academy Clinician/Scientist foundation Hannover Medical School, Germany and the Clinical Leave Clinician/Scientist program of the German Center for Infection Research (DZIF).Conflict of interests: Katharina Schütz and Gesine Hansen received funding from the Deutsche Forschungsgemeinschaft for the Cluster of Excellence EXC2155 “RESIST”-project (ID 39087428).Conflict of interests: Christine Happle received funding from the Young Academy Clinician/Scientist foundation and HiLF funding of Hannover Medical School, Germany and the Excellence Cluster RESIST in infection research.Conflict of interests: Matthias Kopp, Gesine Hansen, Tobias Welte received funding from the German Center for Lung Research (DZL). The other authors received not additional funding.Conflict of interests: The authors have no conflicts of interests for this article to disclose. ER -